Expression of interferon-gamma (IFN-γ), IL-10, IL-12 and transforming growth factor-beta (TGF-β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)

Clinical and Experimental Immunology

Volumn 103, Issue 3, 1996, Pages 357-367

  Bucht, A ^a,b   Larsson, P ^b   Weisbrot, L ^d   Thorne, C ^c   Pisa, P ^a   Smedegard G ^b   Keystone, E C ^d   Gronberg A ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Glaucoma Research   (Sweden)

^c York Central Hospital   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

IL 10; IL 12; IL 4; Interferon gamma; Rheumatoid arthritis; Transforming growth factor beta

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BASE SEQUENCE; BETA 2-MICROGLOBULIN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; SYNOVIAL FLUID; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029670318     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1996.tb08288.x     Document Type: Article

References (55)

1. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 3:305-15.
2. Elliott MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) vs. placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10.
3. Yocum DE, Esparza L, Dubry S, Benjamin JB, Volz R, Scuder P. Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol 1989; 122:131-45.
4. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179:1517-27.
5. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL4 down-regulates IL1 and TNF gene expression in human monocytes. J Immunol 1989; 142:3857-61.
6. Donnelly RP, Fenton MJ, Finbloom DS, Gerrard TL. Differential regulation of IL1 production in human monocytes by IFNγ and IL4. J Immunol 1990; 145:569-75.
7. Oswald IP, Wynn TA, Sher A, James SL. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor a required as a costimulatory factor for interferon γ-induced activation. Proc Natl Acad Sci USA 1992; 89:8676-80.
8. Clerici, M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15:575-81.
9. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFNγ and IL4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148:2142-7.
10. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor a are costimulators of interferon 7 production by natural killer cells in severe combined immunodeficiency mice with listeriosis and inlerleukin 10 is a physiologic antagonist. Proc Natl Acad Sei USA 1993; 90:3725-9.
11. DÁndrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL12 synthesis in accessory cells. J Exp Med 1993; 178:1041-8.
12. Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW. Modulation of the immune response by transforming growth factor beta. Int Arch Allergy 1992; 99:1-7.
13. Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Natl Acad Sci USA 1992; 89:7375-9.
14. Fava RA, Olsen NJ, Postlethwaite AE et al. Transforming growth factor β1 (TGFβ1) induced neutrophil recruitment to synovial tissues: implication for TGFβ-driven synovial inflammation and hyperplasia. J Exp Med 1991; 173:1121-32.
15. Kahle P, Saal G, Schaudt K, Zacher J, Fritz P, Pawelec G. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992; 51:731-4.
16. Firestein GS, Alvaro-Garcia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990; 144:3347-53.
17. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993; 52:870-5.
18. Wood NC, Symons JA, Dickens E, Duff GW. In situ hybridization of IL6 in rheumatoid arthritis. Clin Exp Immunol 1992; 87:183-9.
19. Field M, Chu D, Feldmann M, Maini RN. Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis. Rheumatol Int 1991; 11:45-50.
20. Houssiau FA, Devogelaer JP, van Damme J, de Deuxchaisnes CN, van Snick J. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31:784-8.
21. Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Streiter RM. Synovial tissue macrophage as a source of the chemotactic cytokine IL8. J Immunol 1991; 147:2187-95.
22. Hopkins SJ, Meager A. Cytokines in synovial fluid: II. The presence of tumor necrosis factor and interferon. Clin Exp Immunol 1988; 73:88-92.
23. Xu W, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ. Cytokines in chronic inflammatory arthritis. J Clin Invest 1989; 83:876-82.
24. Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T. Active and latent forms of transforming growth factor β activity in synovial effusions. J Exp Med 1989; 169:291-6.
25. Miossec P, Naviliat M, DÁngeac AD, Sany J, Banchereau J, Low levels of interleukin-4 and high levels of transforming growth factor β in rheumatoid synovitis. Arthritis Rheum 1990; 33:1180-7.
26. Lafyatis R, Thompson NL, Remmers EF et al. Transforming growth factor-β production by synovial tissues from rheumatoid arthritis patients and streptococcal cell wall arthritic rats. J Immunol 1989; 143:1142-8.
27. Saxne T, Palladino MA, Heinegård D, Talal N, Wollheim F. Detection of tumor necrosis factor «but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988; 31:1041-5.
28. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562-6.
29. Llorente L, Richaud-Patin Y, Fior R et al. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis. Sjögren's syndrome, and systemic lupus erythematosus. Arthritis Rheum 1994; 37:1647-55.
30. Potocnik AJ, Kinne R, Menninger H, Zacher J, Emmrich F, Kroczek RA. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 1990; 31:213-24.
31. Iannone F, Corrigall VM, Kingsley GH, Panayi G. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 1994; 24:2706-13.
32. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987; 30:864-71.
33. Yamagata N, Kobayashi K, Kasama T et al. Multiple cytokine activities and loss of inteleukin 2 inhibitor in synovial fluids of patients with rheumatoid arthritis. J Rheumatol 1988; 15:1623-7.
34. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL2), IL2 receptor and IFNγ. Clin Exp Immunol 1988; 71:295-301.
35. Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993; 36:901-10.
36. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
37. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
38. 2-microglobulin. Proc Natl Acad Sci USA 1981; 78:6613-7.
39. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J. Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc Natl Acad Sci USA 1989; 86:8941-5.
40. Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature 1982; 298:859-63.
41. Derynck R, Jarrett JA, Chen EY et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316:701-5.
42. Yokota T, Otsuka T, Mosman T et al. Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that express B-cell- and T-cell-stimulating activities. Proc Natl Acad SCi USA 1986; 83:5894-8.
43. Vieira P, deWaal-Malefyt R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl Acad Sci USA 1991; 88:1172-6.
44. Wolf SF, Temple PA, Kobayashi M et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146:3074-81.
45. Bucht A, Söderström K, Esin S et al. Analysis of γδ V region usage in normal and diseased human intestinal biopsies and peripheral blood by polymerase chain reaction (PCR) and flow cytometry. Clin Exp Immunol 1995; 99:57-64.
46. Réme T, Portier M, Frayssinoux F, Combe B, Miossec P, Favier F, Sany J. T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Arthritis Rheum 1990; 33:485-92.
47. Tang MLK, Varigos G, Kemp AS. Reduced interferon-gamma (IFN-γ) secretion with increased IFN-γ mRNA expression in atopic dermatitis: evidence for a post-transcriptional defect. Clin Exp Immunol 1994; 97:483-90.
48. Oswald IP, Gazzinelli RT, Sher A, James SL. IL10 synergizes with IL4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148:3578-82.
49. Abeshira-Amar O, Gibert M, Joliy M, Théze J, Jankovic D. IL4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 1992; 148:3820-9.
50. Schmitt E, Hoehn P, Huels C, Goedert S, Palm N, Rüde E, Germann T. T helper type 1 development requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-γ. Eur J Immunol 1994; 24:793-8.
51. Kennedy MK, Picha KS, Shanebeck KD, Anderson DM, Grabstein KH. Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones. Eur J Immunol 1994; 24:2271-8.
52. Ling P, Gately MK, Gubler U et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995; 154:116-27.
53. Wahl SM, Allen JB, Wong HL, Dougherthy SF, Ellingsworth LR. Antagonistic and agonistic effects of transforming growth factor-β and IL-I in rheumatoid synovium. J Immunol 1990; 145:2514-9.
54. Olsson T. Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol 1994; 1:7-19.
55. Khoury SJ, Hancock WW, Weiner H. Oral tolerance to myelic basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4 and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355-64.